🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 544191109
- Market Cap
- Small Cap · $160 Million
- Previous Symbol
- LRP
Business: Lorus is a biopharmaceutical company focused on the research and development of novel therapeutics in cancer. Lorus’ goal is to capitalize on its research, preclinical, clinical and regulatory expertise by developing new drug candidates that can be used, either alone, or in combination with other drugs, to successfully manage cancer. The Company also has expertise in antimicrobial drug discovery. Lorus Therapeutics Inc. is listed on the Toronto Stock Exchange under the symbol LOR and on the OTCBB under the symbol LRUSF.
Notes: Lorus Therapeutics Inc. (TSX: LOR; OTCBB: LRUSF) (“Lorus”), a biopharmaceutical company specializing in the discovery and development of pharmaceutical products and technologies for the management of cancer, today announced the approval of the Investigational New Drug (IND) application for its anticancer drug candidate LOR-253 by the U.S. Food & Drug Administration (FDA).
Company Contact
- CEO
- Dr. Jim A. Wright
- CFO
- Ping Wei
- Headquarters
- 2 Meridian Road, Toronto, Ontario M9W 4Z7 Canada
- Phone
- 416-798-1200
- Fax
- 416-798-2200
- Investor Relations
- Grace Tse · 416-798-1200 · ir@lorusthera.com